Acute treatment with relaxin protects the kidney against ischaemia/reperfusion injury

Although recent preclinical and clinical studies have demonstrated that recombinant human relaxin (rhRLX) may have important therapeutic potential in acute heart failure and chronic kidney diseases, the effects of acute rhRLX administration against renal ischaemia/reperfusion (I/R) injury have never...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Collino, Massimo, Rogazzo, Mara, Pini, Alessandro, Benetti, Elisa, Rosa, Arianna Carolina, Chiazza, Fausto, Fantozzi, Roberto, Bani, Daniele, Masini, Emanuela
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley & Sons 2013
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4117562/
https://ncbi.nlm.nih.gov/pubmed/24079335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.12120
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge